Share your feedback in a quick live call and enjoy 6 months of Gainer Pro FREE!🎉 Got 10 minutes? Join a quick live call, share your feedback, and get 6 months of Gainer Pro FREE! 🚀 Only 25 spots - book now!
Share your feedback in a quick live call and enjoy 6 months of Gainer Pro FREE!🎉 Got 10 minutes? Join a quick live call, share your feedback, and get 6 months of Gainer Pro FREE! 🚀 Only 25 spots - book now!
Find the Perfect Plan for Your Investment Journey
Latest price
-
52 Week Range
£9.67K - £13.39K
Next Earnings Date
Apr 29 2025 (Estimate)
Next Earnings Date
Apr 29 2025 (Est.)
Latest price
-
Market Cap | £183.68B |
EV | £203.67B |
Shares Outstanding | 1.55B |
Beta | 0.16 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | £180.36 |
P/E 2025E | 17.26x |
P/Revenue 2025E | 4.16x |
Revenue | 13.10% |
EPS | 15.80% |
Operating Cash Flow | 25.80% |
Free Cash Flow | 26.80% |
Revenue | 6.20% |
EPS | 11.60% |
Operating Cash Flow | 14.00% |
Free Cash Flow | 13.30% |
Gross Margin 2025E | 82.33% |
Net Profit Margin 2025E | 17.34% |
ROE 2025E | 31.44% |
ROCE 2024 | 17.60% |
DPS 2025E | £3.21 |
Payout Ratio 2025E | 35.99% |
Div. Yield 2025E | 2.71% |
DPS Last 3Y CAGR | 2.60% |
AstraZeneca PLC
AZN
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Soriot, Pascal
Employees
94,300
Website
www.astrazeneca.comIPO Date
1993-05-21
Headquarters
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, Cambridgeshire, CB2 0AA, United Kingdom
NEWSLETTER
© Copyright 2024, All Rights Reserved